Sort
40,608 grants matching “prostate cancer”
Project 3
$313,642Anindya Dutta · University Of Virginia · P01 · FY2013 · CA
MI: MODULATING OSTEOCLAST GENE EXPRESSION AND FUNCTION
$313,632Michael C Ostrowski · Ohio State University · R01 · FY2011 · AR
TIMP-1 REGULATORY FACTORS IN HUMAN PROSTATE CANCER
$313,618Drexel University · R01 · FY2002 · CA
Determinants of Response to Type 1 Insulin-Like Growth Factor Inhibition in Prost
$313,602Stephen R Plymate · University Of Washington · P01 · FY2010 · CA
C11 ACETATE PET IMAGING OF PROSTATE AND RENAL CANCER
$313,585University Of Michigan At Ann Arbor · R01 · FY2001 · CA
Interleukin-6 and castration-resistant prostate cancer
$313,560Allen C Gao · University Of California At Davis · R01 · FY2010 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2010 · CA
Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
$313,533Eugene D. Kwon · Mayo Clinic Rochester · R01 · FY2010 · CA
Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
$313,533Eugene D. Kwon · Mayo Clinic Rochester · R01 · FY2009 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2009 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2008 · CA
The role of VEGF-C in resisting stress in prostate cancer
$313,533Kaustubh Datta · Mayo Clinic Rochester · R01 · FY2010 · CA
Role of Androgen Receptor Phosphorylation in Prostate Cancer
$313,524Daniel G Gioeli · University Of Virginia · R01 · FY2010 · CA
Progenitor cells of the mouse prostate epithelium
$313,516Michael M. Shen · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2006 · DK
Targeted Combination Therapy for Breast Cancer
$313,504Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers
$313,491Susan R Mallery · Ohio State University · R01 · FY2010 · CA
Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL
$313,489Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2016 · CA
Project 4: Clinical Development of Therapeutic Strategies Targeting DNA Damage Repair
$313,399Peter S Nelson · Fred Hutchinson Cancer Research Center · P50 · FY2018 · CA
Molecular cancer radiosensitization by targeting Mcl-1
$313,340Liang Xu · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Determinants of Response to Type 1 Insulin-Like Growth Factor Inhibition in Prost
$313,339Stephen R Plymate · University Of Washington · P01 · FY2009 · CA
Role of Kallikrein 6 expression and secretion in colon cancer
$313,336Natalia A Ignatenko · University Of Arizona · R01 · FY2012 · CA
Role of Kallikrein 6 expression and secretion in colon cancer
$313,336Natalia A Ignatenko · University Of Arizona · R01 · FY2015 · CA
Role of Kallikrein 6 expression and secretion in colon cancer
$313,336Natalia A Ignatenko · University Of Arizona · R01 · FY2016 · CA
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???
$313,325Peter Anthony Crooks · Univ Of Arkansas For Med Scis · R01 · FY2012 · CA
Multi-parametric MRI Determination of Prostate Cancer Aggressiveness and Extent
$313,325Gregory John Metzger · University Of Minnesota · R01 · FY2009 · CA